JKJustyna Kaźmierczak

Justyna Kaźmierczak

*This is an algorithmically generated author record based on publicly available information.

Justyna Kaźmierczak has a total of 62 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Effectiveness of Pharmaceutical Counseling in Sore Throat Management According to Patients and Pharmacists

    by Piotr Merks, Sebastian Sikorski, Urszula Religioni, Dariusz Świetlik, Katarzyna Plagens-Rotman, Ewelina Drelich, Justyna Kaźmierczak, Aneta Krolak-Ulińska, Radosław Sierpiński, Zbigniew Doniec

    Background: Primary care overload, limited access to physicians, and rising antimicrobial resistance highlight the role of pharmacists in managing minor ailments such as sore throats. We evaluated pharmacy-based counseling in Poland supported by point-of-care testing and symptomatic therapy. Methods: Multicenter, prospective observational study across 23 community pharmacies. Adults (≥18 years) with sore throat underwent group A streptococcus (GAS) rapid antigen testing. Patients with a positive test result were referred to physicians, while others received pharmacist counseling and ketoprofen throat spray. Standardized questionnaires captured symptom severity, perceived effectiveness, onset/duration, convenience, adherence, and patient-reported outcomes. Results: 142 patients were included. Among ketoprofen users, 98.4% reported improvement, and 75% rated relief ≥8/10. Compared with prior remedies, 88.3% judged ketoprofen more effective, and 86.7% reported faster onset. The spray was convenient for 91.4% of participants; no overdosing occurred. Qualitative feedback emphasized rapid relief, easier swallowing/speaking, and return to daily activities without physician consultation. Conclusions: Polish community pharmacy practice, an integrated sore throat pathway combining point-of-care RADT with structured pharmacist counseling and symptomatic treatment, was feasible, acceptable, and without notable safety concerns. As a pilot, these practice-based findings warrant larger comparative and economic studies to confirm clinical effects and assess potential impact on antibiotic use.


  • Open Access

    Knowledge and Practices Regarding Dietary Supplements Among Healthcare Professionals in Poland

    by Justyna Strocka, Urszula Religioni, Katarzyna Plagens-Rotman, Agnieszka Drab, Piotr Merks, Justyna Kaźmierczak, Eliza Blicharska, Jarosław Pinkas

    Introduction: The growing popularity of dietary supplements in Poland raises the need to verify the knowledge and practices of healthcare workers who have a key role in recommending their use. Understanding these issues is important to ensure patient safety and the correct use of dietary supplements. Therefore, the aim of the study was to examine the level of knowledge, practices, and sources of information on dietary supplements among various professional groups of healthcare workers. Material and Methods: The study conducted from September 2023 to June 2024 involved 743 healthcare professionals, including doctors, pharmacists, and nurses. Data were collected online using an original questionnaire. The questionnaire was placed in portals associated with target groups. Results: A total of 73.49% of respondents declared knowledge of dietary supplements. The most common source of information was scientific articles (42.8%), and only 7.00% of respondents used official sources such as the Chief Sanitary Inspectorate. Advertisements had a smaller impact on doctors (p < 0.001), with 46.97% of respondents stating that they did not pay attention to them. In addition, 84.52% of respondents considered the composition of the dietary supplement to be a key factor in their recommendation. Conclusions: Knowledge of dietary supplements among healthcare professionals varies, particularly between different professional groups. The results indicate a need for further education and standardization of information to ensure safe and responsible recommendation of supplements to consumers.


  • Open Access

    Advancing Pharmaceutical Care in Community Pharmacies in Poland: A Blueprint for Enhanced Patient Care Quality

    by Piotr Merks, Anna Kowalczuk, Aleksandra Howell, Artur Białoszewski, Justyna Strocka, Ewa Krajewska, Jarosław Pinkas, Janusz Ostrowski, Anna Staniszewska, Agnieszka Neumann-Podczaska, et al.

    Background: This article reviews the current state of pharmaceutical care in community pharmacies in Poland and proposes a collaborative framework for its advancement. While pharmaceutical care has evolved significantly worldwide, with Europe leading the way, Poland has lagged in its development. Although Polish pharmacists are well-qualified and community pharmacies are numerous, pharmaceutical care remains underdeveloped. Methods: We conducted a literature review and analyzed case studies from European countries with advanced pharmaceutical services. Based on these findings, we collaborated with policy makers, commissioners, and academics to develop a framework for enhancing pharmaceutical care in Poland. The plan emphasizes integrating seven key services into Polish community pharmacies. Results: Our proposed framework outlines seven essential pharmaceutical services: medicine use reviews, new medicine services, minor ailment services, repeat prescription services, integrated prevention programs, cardiovascular disease prevention programs, and vaccination programs. Evidence from other European countries suggests that implementing these services could significantly improve health outcomes and patient quality of life. This is particularly important in light of Poland’s ageing population, the rising prevalence of chronic diseases, and the healthcare system’s increasing burden due to polypharmacy. Conclusions: The proposed framework presents a practical and collaborative approach to advancing pharmaceutical care in Poland. By adopting these key services, community pharmacies could play a more integral role in improving patient care quality and alleviating pressure on the broader healthcare system.


  • Open Access

    Implementation of the Patient Counselling Service at the Cancer Hospital in Radom, Poland

    by Katarzyna Grzyb, Martyna Meresińska, Urszula Religioni, Grzegorz Juszczyk, Jakub Płaczek, Agnieszka Neumann-Podczaska, Filip M. Szymański, Beata Chełstowska, Katarzyna Wieczorowska-Tobis, Szczepan Cofta, et al.

    Background: Non-adherence occurs in various groups of patients, including those with chronic diseases. One strategy to increase adherence among oncological patients is to individualise treatment and expand pharmaceutical care. Pharmaceutical labels that remind patients how they should take their medications are of great importance in this respect. Objective: The main objective of this study was to evaluate medication adherence in oncological patients, and to gather their opinions on the individual medication labelling system as an element of effective treatment. Methods: The study was conducted in 2021 among 82 patients of the oncological department of the Centre of Oncology in Radom. The research tool was a questionnaire consisting of personal data and two parts relating to the patient’s disease and the medication labelling system. Results: Nearly half of the respondents reported that they forget to take medications and how they should take them. These problems increased with the age of the patient and the number of administered medications. Of the respondents, 89% stated that the labels with dosing information are helpful. Over 67% agreed that these labels should be affixed to all medications. Nearly 90% of the respondents believed the labels should be available in all pharmacies. Conclusions: Non-adherence is a common phenomenon among oncological patients. Pharmacists providing a labelling service for medicinal products can play a significant role in reducing this phenomenon.

  • Open Access

    Deploying and Maintaining Standards of New Pharmacy Services Provision in Poland-Introducing the National Pharmacist Competencies Assessment Tool: Pre-Registration Exam–Results of the Pilot Project

    by Piotr Merks, Urszula Religioni, Aleksandra Howell, Marvin Munzu, Edwin Panford-Quainoo, Agnieszka Neumann-Podczaska, Radosław Jaskólski, Beata Kaczmarek, Justyna Kaźmierczak, Eliza Blicharska, et al.

    Despite the functioning of the Bologna Declaration, the knowledge and skills of graduates educated in different countries may differ significantly. Therefore, this article aims to present the differences in results of the final exam in pharmacy among Polish pharmacy students. This exam was modeled on the British national exam supervised by the General Pharmaceutical Council. The exam was conducted in three cities in Poland, among a total of 175 final-year students (a full sample of those eligible was 451 with 276 refusals (38.58% response rate)). Taking the exam was voluntary and anonymous. The results indicate that none of the Polish students achieved the 70% mark required to pass the Great Britain exam. Significant differences in test results were noticed between cities. Students achieved the best average exam result in Bydgoszcz (46.35%), then in Warsaw (38.81%) and Łódź (38.35%). The pharmaceutical education system in Poland requires complete changes that will prepare future pharmacists for clinical work.


  • Open Access

    Falsified Medicines Directive in a Secondary Care Environment—Impact on Supply Chain

    by Piotr Merks, Urszula Religioni, Nuno Pinto de Castro, Anna Augustynowicz, Katarzyna Plagens-Rotman, David Brindley, Anna Kowalczuk, Justyna Kaźmierczak, Agnieszka Neumann-Podczaska, Eliza Blicharska, et al.

    The Falsified Medicines Directive (FMD) and the Delegated Regulation (DR) impact the pharmaceutical supply chain. Ahead of the deadline for implementation, in February 2019, every entity of the supply chain had to adapt its operations to the regulatory requirements to be compliant with the directive. This paper analyzes the supply chain of a hospital pharmacy and the impact of the FMD implementation. Furthermore, a cost analysis was performed demonstrating that the FMD increases expenditure in the secondary care environment dispensing operations. Governments should be aware that this regulation will certainly impact public healthcare institutions in the long term.


  • Open Access

    Patient Perceptions on Receiving Vaccination Services through Community Pharmacies

    by Anna Kowalczuk, Alexandre Wong, Kevin Chung, Urszula Religioni, Dariusz Świetlik, Katarzyna Plagens-Rotman, Jameason D. Cameron, Agnieszka Neumann-Podczaska, Katarina Fehir Šola, Justyna Kazmierczak, et al.

    (1) Introduction: Pharmacists are medical professionals who play an active role in the protection of public health. Since 2021, pharmacists with an appropriate certification have been authorised to administer vaccines against COVID-19. (2) Objective: The objective of this study was to ascertain the perceptions of patients about receiving vaccinations through community pharmacies. (3) Material and methods: This study was conducted in 2021. The research tool was an anonymous questionnaire published on the websites of patient organisations. Ultimately, 1062 patients participated in this study. (4) Results: This study shows that most of the respondents find community pharmacies more accessible than outpatient clinics (85.3%). Sixty-one percent of the respondents stated that getting vaccinated at pharmacies would be less time consuming than at outpatient clinics. Nearly every third respondent (29.5%) declared that they would get vaccinated if they received such a recommendation from a pharmacist. Fifty-six percent of the respondents were of the opinion that the administration of vaccines by pharmacists would relieve the burden on medical staff and the healthcare system. (5) Conclusions: Polish patients participating in the study have a positive attitude towards the implementation of vaccination services in community pharmacies as an effective way of combating infectious diseases.


  • Open Access

    The Quality and Reliability of Information in the Summaries of Product Characteristics

    by Ewelina Drelich, Urszula Religioni, Kevin Chung, Justyna Kaźmierczak, Eliza Blicharska, Agnieszka Neumann-Podczaska, Jerzy Krysiński, Piotr Merks

    The Summary of Product Characteristics (SmPC) is an obligatory document concerning a medicine required (among other things) for the authorization of a medicinal product. The purpose of the SmPC is to provide product information to healthcare professionals. A necessary condition for this is to ensure that the SmPC is clear and precise. However, neither European nor national legislation obliges marketing authorization holders to review the SmPC in terms of its readability and understandability prior to the registration of a medicine. To date, research on SmPCs has focused on accuracy and completeness; however, the literature lacks information on the extent to which SmPCs meet the needs of healthcare professionals concerning the readability of the information they contain. The main objective of this article is to point out the lack of precision in the legal provisions for the preparation of SmPCs concerning the comprehensibility of the provisions. The article points to the lack of testing of the SmPC in terms of accessibility and transparency for healthcare professionals, highlighting that the document does not meet the needs of healthcare professionals in providing adequate information about medicines. It shows that the current rules and guidelines for the preparation of the registration dossier for a medicinal product are not entirely precise and contain numerous shortcomings.


  • Open Access

    Assessment of Pharmacists’ Willingness to Conduct Medication Use Reviews in Poland

    by Piotr Merks, Urszula Religioni, Magdalena Waszyk-Nowaczyk, Justyna Kaźmierczak, Artur Białoszewski, Eliza Blicharska, Anna Kowalczuk, Agnieszka Neumann-Podczaska

    Introduction. Pharmacists play an important role in healthcare. Their functions are evolving and, in many countries, they actively participate in interdisciplinary patient treatment. One of the most common services provided by pharmacists as part of pharmaceutical care in community pharmacies involves medication reviews. Objective. The objective of this study was to evaluate the readiness of pharmacists to conduct medication reviews in community pharmacies. Materials and methods. This study comprises 493 pharmacists from community pharmacies in Poland. A questionnaire (developed for the purposes of this study) was used. It consisted of eight questions regarding readiness to conduct medication reviews, along with personal data. Results. A total of 63.9% of the pharmacists were ready to conduct medication reviews, and 23.1% already had experience in this area. Participants were of the opinion that this service should be funded by the Ministry of Health or a third-party public payer, and overall was valued by the participants at PLN 169.04 (SD = 280.77) net per patient. Conclusions. Pharmacists in Poland have expressed their readiness to conduct medical reviews. Implementation of this service in community pharmacies in Poland can have a significant impact on optimising patient health outcomes.